Christine E. Fernando is a Carmichael, California based female rheumatologist who is specialized in Rheumatology. Active license number of Christine E. Fernando for Rheumatology is A33155 in California. Christine E. Fernando treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Christine E. Fernando speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1962580605
NPI Enumeration Date:
01 Nov, 2006
NPI Last Update On:
23 Sep, 2009
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Christine E. Fernando are as mentioned below.
License Number
Specialization
State
Status
A33155
Rheumatologist
California
Primary
Other Medical Identifiers:
Other legacy medical identifiers associated with Christine E. Fernando such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
00A331550
Medicaid
California
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1516 Kingsford Dr, Carmichael, California
Zip:
95608-5967
Phone Number:
916-485-3428
Fax Number:
--
Patients can reach Christine E. Fernando at 1516 Kingsford Dr, Carmichael, California or can call to book an appointment on 916-485-3428. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.